@article{81f8cf8a345e4cb3b18f137336681969,
title = "Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy",
abstract = "The purpose of this study was to determine whether a diuretic effect may be detectable in patients treated with eplerenone, a mineralocorticoid receptor antagonist, as compared with placebo during the first month of EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival study) (n = 6,080) and whether this was associated with eplerenone's beneficial effects on cardiovascular outcomes.",
keywords = "Aged, Aldosterone Antagonists, Clinical Trials as Topic, Diuresis, Female, Heart Failure, Humans, Male, Middle Aged, Potassium, Spironolactone",
author = "Patrick Rossignol and Jo{\"e}l M{\'e}nard and Renaud Fay and Finn Gustafsson and Bertram Pitt and Faiez Zannad",
note = "Copyright {\textcopyright} 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.",
year = "2011",
doi = "10.1016/j.jacc.2011.04.049",
language = "English",
volume = "58",
pages = "1958--66",
journal = "American College of Cardiology. Journal",
issn = "0735-1097",
publisher = "Elsevier Inc.",
number = "19",
}